{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T03:01:54Z","timestamp":1773889314585,"version":"3.50.1"},"reference-count":35,"publisher":"Impact Journals, LLC","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Oncotarget"],"published-print":{"date-parts":[[2015,1,30]]},"DOI":"10.18632\/oncotarget.2837","type":"journal-article","created":{"date-parts":[[2015,9,16]],"date-time":"2015-09-16T21:36:41Z","timestamp":1442439401000},"page":"1507-1518","source":"Crossref","is-referenced-by-count":15,"title":["HS-543 induces apoptosis of Imatinib-resistant chronic myelogenous leukemia with T315I mutation"],"prefix":"10.18632","volume":"6","author":[{"given":"Soo Jung","family":"Kim","sequence":"first","affiliation":[{"name":"College of Medicine, Inha University, Sinheung-dong, Jung-gu, Incheon, Republic of Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kyung Hee","family":"Jung","sequence":"additional","affiliation":[{"name":"College of Medicine, Inha University, Sinheung-dong, Jung-gu, Incheon, Republic of Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hong Hua","family":"Yan","sequence":"additional","affiliation":[{"name":"College of Medicine, Inha University, Sinheung-dong, Jung-gu, Incheon, Republic of Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mi Kwon","family":"Son","sequence":"additional","affiliation":[{"name":"College of Medicine, Inha University, Sinheung-dong, Jung-gu, Incheon, Republic of Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhenghuan","family":"Fang","sequence":"additional","affiliation":[{"name":"College of Medicine, Inha University, Sinheung-dong, Jung-gu, Incheon, Republic of Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ye-Lim","family":"Ryu","sequence":"additional","affiliation":[{"name":"College of Medicine, Inha University, Sinheung-dong, Jung-gu, Incheon, Republic of Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hyunseung","family":"Lee","sequence":"additional","affiliation":[{"name":"College of Medicine, Inha University, Sinheung-dong, Jung-gu, Incheon, Republic of Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joo Han","family":"Lim","sequence":"additional","affiliation":[{"name":"College of Medicine, Inha University, Sinheung-dong, Jung-gu, Incheon, Republic of Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jun-Kyu","family":"Suh","sequence":"additional","affiliation":[{"name":"National Research Center for Sexual Medicine, College of Medicine, Inha University, Sinheung-dong, Jung-gu, Incheon, Republic of Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"JinHee","family":"Kim","sequence":"additional","affiliation":[{"name":"Center for Catalytic Hydrocarbon Functionalizations, Institute for Basic Science (IBS), Republic of Korea"},{"name":"Department of Chemistry, Korea Advanced Institute of Science and Technology (KAIST), Daejeon, Republic of Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Soyoung","family":"Lee","sequence":"additional","affiliation":[{"name":"Center for Catalytic Hydrocarbon Functionalizations, Institute for Basic Science (IBS), Republic of Korea"},{"name":"Department of Chemistry, Korea Advanced Institute of Science and Technology (KAIST), Daejeon, Republic of Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sungwoo","family":"Hong","sequence":"additional","affiliation":[{"name":"Center for Catalytic Hydrocarbon Functionalizations, Institute for Basic Science (IBS), Republic of Korea"},{"name":"Department of Chemistry, Korea Advanced Institute of Science and Technology (KAIST), Daejeon, Republic of Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Soon-Sun","family":"Hong","sequence":"additional","affiliation":[{"name":"College of Medicine, Inha University, Sinheung-dong, Jung-gu, Incheon, Republic of Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"7892","published-online":{"date-parts":[[2014,12,2]]},"reference":[{"issue":"6","key":"1","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1038\/nrc2147","article-title":"Chronic myeloid leukaemia as a model of disease evolution in human cancer","volume":"7","author":"Barnes","year":"2007","journal-title":"Nat Rev Cancer"},{"issue":"10","key":"2","doi-asserted-by":"crossref","first-page":"3219","DOI":"10.1158\/1078-0432.CCR-11-0234","article-title":"HDAC inhibitors potentiate the activity of the BCR\/ABL kinase inhibitor KW-2449 in imatinib-sensitive or -resistant BCR\/ABL+ leukemia cellsand","volume":"17","author":"Grant","year":"2011","journal-title":"Clin Cancer Res"},{"issue":"2","key":"3","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.canlet.2009.09.006","article-title":"Celastrol, a novel HSP90 inhibitor, depletes Bcr-Abl and induces apoptosis in imatinib-resistant chronic myelogenous leukemia cells harboring T315I mutation","volume":"290","author":"Pan","year":"2010","journal-title":"Cancer Lett"},{"issue":"4","key":"4","first-page":"484","article-title":"Kinase-addiction and bi-phasic sensitivity-resistance of Bcr-Abl- and Raf-1-expressing cells to imatinib and geldanamycin","volume":"4","author":"Blagosklonny","year":"2005","journal-title":"Cancer Biol Ther"},{"issue":"2","key":"5","first-page":"121","article-title":"Nilotinib: a novel encouraging therapeutic option for chronic myeloid leukemia patients with imatinib resistance or intolerance","volume":"1","author":"Baccarani","year":"2007","journal-title":"Biologics"},{"issue":"5531","key":"6","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1126\/science.1062538","article-title":"Clinical resistance to STI-571 cancer therapy caused by BCR-ABL gene mutation or amplification","volume":"293","author":"Sawyers","year":"2001","journal-title":"Science"},{"issue":"4","key":"7","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1038\/sj.leu.2402409","article-title":"STI-571 must select for drug-resistant cells but \u2018no cell breathes fire out of its nostrils like a dragon\u2019","volume":"16","author":"Blagosklonny","year":"2002","journal-title":"Leukemia"},{"issue":"9","key":"8","doi-asserted-by":"crossref","first-page":"3531","DOI":"10.1021\/jm301891t","article-title":"Discovery of new benzothiazole-based inhibitors of breakpoint cluster region-Abelson kinase including the T315I mutant","volume":"56","author":"Hong","year":"2013","journal-title":"J Med Chem"},{"issue":"3","key":"9","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1111\/j.1747-0285.2007.00556.x","article-title":"Crystal structure of the T315I mutant of AbI kinase","volume":"70","author":"Zhu","year":"2007","journal-title":"Chem Biol Drug Des"},{"issue":"14","key":"10","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1002\/(SICI)1096-987X(19981115)19:14<1639::AID-JCC10>3.0.CO;2-B","article-title":"Automated Docking Using a Lamarckian Genetic Algorithm and an Empirical Binding Free Energy Function","volume":"19","author":"Olson","year":"1998","journal-title":"J Comput Chem"},{"issue":"12","key":"11","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1016\/S0962-8924(01)02173-0","article-title":"Programmed cell death: alive and well in the new millennium","volume":"11","author":"Hengartner","year":"2001","journal-title":"Trends Cell Biol"},{"issue":"12","key":"12","first-page":"1369","article-title":"Phosphoproteomic fingerprinting of epidermal growth factor signaling and anticancer drug action in human tumor cells","volume":"2","author":"Epstein","year":"2003","journal-title":"Mol Cancer Ther"},{"issue":"45","key":"13","doi-asserted-by":"crossref","first-page":"16870","DOI":"10.1073\/pnas.0606509103","article-title":"Targeting multiple kinase pathways in leukemic progenitors and stem cells is essential for improved treatment of Ph+ leukemia in mice","volume":"103","author":"Li","year":"2006","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"5","key":"14","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1038\/nm0596-561","article-title":"Effects of a selective inhibitor of the Abl tyrosine kinase on the growth of Bcr-Abl positive cells","volume":"2","author":"Lydon","year":"1996","journal-title":"Nat Med"},{"issue":"7","key":"15","first-page":"1661","article-title":"Selective inhibition of cell proliferation and BCR-ABL phosphorylation in acute lymphoblastic leukemia cells expressing Mr 190,000 BCR-ABL protein by a tyrosine kinase inhibitor (CGP-57148)","volume":"4","author":"Kantarjian","year":"1998","journal-title":"Clin Cancer Res"},{"issue":"24","key":"16","doi-asserted-by":"crossref","first-page":"2531","DOI":"10.1056\/NEJMoa055229","article-title":"Dasatinib in imatinib-resistant Philadelphia chromosome-positive leukemias","volume":"354","author":"Sawyers","year":"2006","journal-title":"N Engl J Med"},{"key":"17","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1186\/1476-4598-6-67","article-title":"Nilotinib treatment in mouse models of P190 Bcr\/Abl lymphoblastic leukemia","volume":"6","author":"Heisterkamp","year":"2007","journal-title":"Mol Cancer"},{"issue":"11","key":"18","doi-asserted-by":"crossref","first-page":"2621","DOI":"10.1002\/ijc.23435","article-title":"Overcoming imatinib resistance using Src inhibitor CGP76030, Abl inhibitor nilotinib and Abl\/Lyn inhibitor INNO-406 in newly established K562 variants with BCR-ABL gene amplification","volume":"122","author":"Ueda","year":"2008","journal-title":"Int J Cancer"},{"issue":"7","key":"19","doi-asserted-by":"crossref","first-page":"1924","DOI":"10.1158\/1535-7163.MCT-09-0168","article-title":"Gene expression profiling of imatinib and PD166326-resistant CML cell lines identifies Fyn as a gene associated with resistance to BCR-ABL inhibitors","volume":"8","author":"Auberger","year":"2009","journal-title":"Mol Cancer Ther"},{"issue":"17","key":"20","first-page":"1673","article-title":"Second-generation BCR-ABL kinase inhibitors in CML","volume":"363","author":"Haznedaroglu","year":"2010","journal-title":"N Engl J Med"},{"issue":"5","key":"21","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1038\/sj.cdd.4401210","article-title":"Bcr-Abl-mediated resistance to apoptosis is independent of constant tyrosine-kinase activity","volume":"10","author":"Amarante-Mendes","year":"2003","journal-title":"Cell Death Differ"},{"issue":"21","key":"22","doi-asserted-by":"crossref","first-page":"5766","DOI":"10.1093\/emboj\/cdf562","article-title":"The Src family kinase Hck couples BCR\/ABL to STAT5 activation in myeloid leukemia cells","volume":"21","author":"Skorski","year":"2002","journal-title":"EMBO J"},{"issue":"8","key":"23","doi-asserted-by":"crossref","first-page":"2940","DOI":"10.1182\/blood-2002-04-1204","article-title":"Signal transducer and activator of transcription proteins in leukemias","volume":"101","author":"Wetzler","year":"2003","journal-title":"Blood"},{"issue":"4","key":"24","first-page":"1398","article-title":"Crkl enhances leukemogenesis in BCR\/ABL P190 transgenic mice","volume":"61","author":"Heisterkamp","year":"2001","journal-title":"Cancer Res"},{"issue":"4","key":"25","first-page":"839","article-title":"The proto-oncogene product p120CBL and the adaptor proteins CRKL and c-CRK link c-ABL, p190BCR\/ABL and p210BCR\/ABL to the phosphatidylinositol-3\u2032 kinase pathway","volume":"12","author":"Griffin","year":"1996","journal-title":"Oncogene"},{"issue":"2","key":"26","first-page":"75","article-title":"Immunoreactivity of Stat5 phosphorylated on tyrosine as a cell-based measure of Bcr\/Abl kinase activity","volume":"54","author":"Goolsby","year":"2003","journal-title":"Cytometry A"},{"issue":"3","key":"27","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1006\/bbrc.1997.6353","article-title":"Release of cytochrome c from liver mitochondria during permeability transition","volume":"232","author":"Piantadosi","year":"1997","journal-title":"Biochem Biophys Res Commun"},{"key":"28","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1016\/j.bbabio.2006.03.014","article-title":"Mitochondrial subpopulations and heterogeneity revealed by confocal imaging: possible physiological role?","volume":"1757","author":"Margreiter","year":"2006","journal-title":"Biochim Biophys Acta"},{"issue":"4","key":"29","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1016\/j.bbamcr.2010.10.017","article-title":"Bcl-2 proteins and mitochondria--specificity in membrane targeting for death","volume":"1813","author":"Gilmore","year":"2011","journal-title":"Biochim Biophys Acta"},{"issue":"2","key":"30","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1042\/BJ20100814","article-title":"Survivin and IAP proteins in cell-death mechanisms","volume":"430","author":"Altieri","year":"2010","journal-title":"Biochem J"},{"issue":"11","key":"31","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1038\/sj.onc.1201664","article-title":"Bcl-2-independent Bcr-Abl-mediated resistance to apoptosis: protection is correlated with up regulation of Bcl-xL","volume":"16","author":"Green","year":"1998","journal-title":"Oncogene"},{"issue":"6","key":"32","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1084\/jem.191.6.977","article-title":"Blockade of the Bcr-Abl kinase activity induces apoptosis of chronic myelogenous leukemia cells by suppressing signal transducer and activator of transcription 5-dependent expression of Bcl-xL","volume":"191","author":"Fernandez-Luna","year":"2000","journal-title":"J Exp Med"},{"issue":"12","key":"33","doi-asserted-by":"crossref","first-page":"3421","DOI":"10.1182\/blood-2009-11-255232","article-title":"The STAT5 inhibitor pimozide decreases survival of chronic myelogenous leukemia cells resistant to kinase inhibitors","volume":"117","author":"Frank","year":"2011","journal-title":"Blood"},{"issue":"12","key":"34","doi-asserted-by":"crossref","first-page":"3409","DOI":"10.1182\/blood-2009-10-248211","article-title":"High STAT5 levels mediate imatinib resistance and indicate disease progression in chronic myeloid leukemia","volume":"117","author":"Sexl","year":"2011","journal-title":"Blood"},{"issue":"41","key":"35","doi-asserted-by":"crossref","first-page":"5826","DOI":"10.1038\/sj.onc.1204549","article-title":"Cooperative and redundant effects of STAT5 and Ras signaling in BCR\/ABL transformed hematopoietic cells","volume":"20","author":"Daley","year":"2001","journal-title":"Oncogene"}],"container-title":["Oncotarget"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.2837","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,13]],"date-time":"2020-05-13T09:28:23Z","timestamp":1589362103000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.2837"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,12,2]]},"references-count":35,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2015,1,30]]}},"alternative-id":["2837","25483100"],"URL":"https:\/\/doi.org\/10.18632\/oncotarget.2837","relation":{},"ISSN":["1949-2553"],"issn-type":[{"value":"1949-2553","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,12,2]]}}}